NUS1 - middle region Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-NUS1 - middle region antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | NUS1 - middle region |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | With DHDDS, forms the dehydrodolichyl diphosphate synthase (DDS) complex, an essential component of the dolichol monophosphate (Dol-P) biosynthetic machinery. Adds multiple copies of isopentenyl pyrophosphate (IPP) to farnesyl pyrophosphate (FPP) to produce dehydrodolichyl diphosphate (Dedol-PP), a precusrosor of dolichol which is utilized as a sugar carrier in protein glycosylation in the endoplasmic reticulum (ER). Regulates the glycosylation and stability of nascent NPC2, thereby promoting trafficking of LDL-derived cholesterol. Acts as a specific receptor for the N-terminus of Nogo-B, a neural and cardiovascular regulator. |
| Immunogen | Immunogen: The immunogen is a synthetic peptide directed towards the middle region of human NUS1 |
| Other Names | [dehydrodolichyl diphosphate synthase complex subunit NUS1; Nogo-B receptor; dehydrodolichyl diphosphate synthase complex subunit NUS1; NUS1 dehydrodolichyl diphosphate synthase subunit; Nuclear undecaprenyl pyrophosphate synthase 1 homolog] |
| Gene, Accession # | [NUS1], Gene ID: 116150, NCBI: NP_612468.1, UniProt: Q96E22 |
| Catalog # | MBS3222005 |
| Price | $335 |
| Order / More Info | NUS1 - middle region Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies